Home News & Events Events Webinars Webinars Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Category Regulatory Intelligence Biotech Cardiovascular Cell and Gene Therapies Digital Disruption Early Clinical Infectious Disease Internal Medicine & Immunology Laboratories Medical Imaging Oncology Pediatrics Patient Centricity Rare & Orphan Diseases Real World Intelligence Vaccines Value Based Healthcare Women's Health Webinars ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change Date 16 December 2025 Time 09:30 - 10:30 Location Webinar Timezone EST - America/New York Webinars Joint Clinical Assessment 2025 Date 10 April 2025 Time 10:00 - 11:00 Location Webinar Timezone EST - America/New York Webinars FDA guidance on use of Data Monitoring Committees in Clinical Trials Date 15 October 2024 Time 11:00 - 12:00 Location Webinar Timezone America/New York Webinars Regulatory Submission Writing for NDA Success Date 10 September 2024 Time 11:00 - 12:00 Location Webinar Timezone America/New York ICON’s Webinar Channel A library of recorded webinars exploring topics ranging from early to late phase. Subscribe Today In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions ICON's Webinar channel Event Workshops Event Industry events What's happening in ICON ICON Plc First in human development of oligonucleotide drugs requires careful safety evaluation as molecular complexity increases. In this webinar, ICON specialists discuss best practices for FIH ON study design and risk mitiga... 25 May View post View webpage ICON Plc Oligonucleotide (ON) drug development is accelerating rapidly—but first in human (FIH) studies remain complex. Join our upcoming webinar to explore key translational and clinical considerations for initiating FIH antis... 13 May View post View webpage ICON Plc Great discussion recently at European Pharmaceutical Review’s webinar, “Harnessing AI for more efficient clinical trials.” ICON’s SVP of Enterprise AI, Tony Clarke, joined a panel of industry leaders to share perspectiv... 30 Apr View post View webpage ICON Plc ICON’s Patient Centred Outcomes team delivered strong progress in 2025. – Over 45 specialists across Europe and North America – Twelve peer‑reviewed papers and two webinars – Methodological depth across COA strategy, psy... 31 Mar View post View webpage ICON Plc As the CRA role evolves, so do the opportunities for career progression. From In-House CRA to Clinical Trial Manager, Huseyin's journey highlights how roles are expanding and creating new opportunities for growth. Regi... 23 Mar View post View webpage ICON Plc Patient led organisations are actively shaping scientific and regulatory pathways in ultra rare diseases. Our recent webinar captured powerful examples of how real people are accelerating progress to meet needs, deliver ... 23 Mar View post View webpage ICON Plc Thank you to everyone who joined our Rare Disease Day webinar. The inspiring discussion highlighted the results of patients’ and parents’ relentless advocacy, including scientific breakthroughs and regulatory progress in... 23 Mar 1 View post View webpage ICON Plc Missed our Rare Disease Day webinar or want to rewatch the discussion? Hear real world examples of how patient led organisations are breaking barriers in ultra rare disease drug development. Watch the recording today: ht... 17 Mar 1 View post View webpage ICON Plc Join us to explore the latest best practices in global flow cytometry QC and harmonisation. During this webinar hosted by Bioanalysis Zone ICON’s flow cytometry specialists will discuss: - Industry best practices for h... 3 Mar View post View webpage ICON Plc Ultra rare disease progress does not happen by accident. Register for our webinar to hear how patient leaders are accelerating therapies and redefining what is possible through practical, repeatable expert‑proven model... 26 Feb View post View webpage ICON Plc In recognition of Rare Disease Day, join ICON’s Centre for Rare Diseases for an inspiring panel at our upcoming webinar on 3 March at 11 am EST. Hear directly from parent and patient leaders whose advocacy is driving f... 24 Feb View post View webpage
